Bank of New York Mellon’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.04M Buy
152,451
+14,321
+10% +$577K ﹤0.01% 2232
2026
Q1
$4.58M Buy
138,130
+3,415
+3% +$111K ﹤0.01% 2366
2025
Q4
$4.41M Sell
134,715
-3,257
-2% -$80.1K ﹤0.01% 2390
2025
Q3
$2.46M Buy
137,972
+2,735
+2% +$39.7K ﹤0.01% 2693
2025
Q2
$1.47M Buy
135,237
+7,108
+6% +$93.1K ﹤0.01% 2899
2025
Q1
$2.37M Sell
128,129
-1,557
-1% -$28.1K ﹤0.01% 2608
2024
Q4
$2.14M Sell
129,686
-1,764
-1% -$25K ﹤0.01% 2734
2024
Q3
$1.84M Sell
131,450
-29,442
-18% -$326K ﹤0.01% 2792
2024
Q2
$1.16M Buy
160,892
+13,798
+9% +$94.3K ﹤0.01% 3104
2024
Q1
$1.19M Sell
147,094
-8,329
-5% -$74.6K ﹤0.01% 3056
2023
Q4
$1.06M Buy
155,423
+20,333
+15% +$113K ﹤0.01% 3155
2023
Q3
$675K Buy
135,090
+266
+0.2% +$1.84K ﹤0.01% 3398
2023
Q2
$1.23M Buy
134,824
+3,146
+2% +$29.3K ﹤0.01% 3086
2023
Q1
$1.24M Sell
131,678
-3,763
-3% -$34.4K ﹤0.01% 3048
2022
Q4
$1.35M Sell
135,441
-1,867
-1% -$20.7K ﹤0.01% 3049
2022
Q3
$1.64M Buy
137,308
+12,170
+10% +$122K ﹤0.01% 2958
2022
Q2
$1.02M Buy
125,138
+3,910
+3% +$33.4K ﹤0.01% 3199
2022
Q1
$962K Buy
121,228
+483
+0.4% +$4.17K ﹤0.01% 3342
2021
Q4
$1.13M Buy
120,745
+2,609
+2% +$31.3K ﹤0.01% 3316
2021
Q3
$1.87M Buy
118,136
+7,615
+7% +$137K ﹤0.01% 3020
2021
Q2
$2.39M Sell
110,521
-22,787
-17% -$461K ﹤0.01% 2877
2021
Q1
$2.7M Sell
133,308
-6,470
-5% -$128K ﹤0.01% 2755
2020
Q4
$2.5M Sell
139,778
-3,875
-3% -$56.9K ﹤0.01% 2709
2020
Q3
$1.67M Sell
143,653
-357,307
-71% -$4.15M ﹤0.01% 2766
2020
Q2
$4.63M Sell
500,960
-322,094
-39% -$2.89M ﹤0.01% 2238
2020
Q1
$8.56M Sell
823,054
-52,771
-6% -$672K ﹤0.01% 1783
2019
Q4
$15.7M Sell
875,825
-121,520
-12% -$1.8M ﹤0.01% 1713
2019
Q3
$12.4M Sell
997,345
-107,638
-10% -$1.77M ﹤0.01% 1809
2019
Q2
$21.9M Buy
1,104,983
+27,616
+3% +$591K 0.01% 1522
2019
Q1
$22.7M Sell
1,077,367
-147,460
-12% -$2.69M 0.01% 1476
2018
Q4
$25M Buy
1,224,827
+121,856
+11% +$3.81M 0.01% 1325
2018
Q3
$40.6M Buy
1,102,971
+199,885
+22% +$8.73M 0.01% 1168
2018
Q2
$45.4M Buy
903,086
+25,748
+3% +$1.13M 0.01% 1067
2018
Q1
$32M Buy
877,338
+27,345
+3% +$839K 0.01% 1263
2017
Q4
$24.1M Buy
849,993
+218,430
+35% +$5.15M 0.01% 1458
2017
Q3
$12.2M Buy
631,563
+471,209
+294% +$7.92M ﹤0.01% 1886
2017
Q2
$2.69M Buy
160,354
+71,609
+81% +$966K ﹤0.01% 2669
2017
Q1
$928K Sell
88,745
-575
-0.6% -$5.86K ﹤0.01% 3285
2016
Q4
$804K Buy
89,320
+7,560
+9% +$65.1K ﹤0.01% 3378
2016
Q3
$738K Buy
81,760
+1,180
+1% +$9.59K ﹤0.01% 3338
2016
Q2
$555K Buy
80,580
+53,427
+197% +$302K ﹤0.01% 3482
2016
Q1
$146K Hold
27,153
﹤0.01% 3879
2015
Q4
$136K Hold
27,153
﹤0.01% 3982
2015
Q3
$112K Buy
+27,153
New +$109K ﹤0.01% 4078
2014
Q1
Sell
-10,001
Closed -$45K 4183
2013
Q4
$45K Hold
10,001
﹤0.01% 4119
2013
Q3
$44K Buy
+10,001
New +$36.7K ﹤0.01% 4056

Other funds holding AXGN

Bank of New York Mellon's AXGN Position: Q2 2026 in Review

Bank of New York Mellon increased its Axogen (AXGN) stake by 10% in Q2 2026, buying an estimated $577K and bringing the position to 152,451 shares worth $7.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2232.

Bank of New York Mellon first reported a position in AXGN in Q3 2013 and has held it in 46 quarters since. The position peaked at $45.4M in Q2 2018. 86 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Bank of New York Mellon held 152,451 shares of Axogen worth $7.04M as of Q2 2026.
  • Bank of New York Mellon bought 14,321 Axogen shares in Q2 2026, an estimated $577K.
  • Axogen made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2232 holding.
  • Bank of New York Mellon first reported a position in Axogen in Q3 2013 and has held it in 46 quarters since.
  • Bank of New York Mellon's Axogen position peaked at $45.4M in Q2 2018.
  • 86 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.